<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang HY</submitter><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>1443-1450</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10018702</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(12)</volume><pubmed_abstract>Ternatin-family cyclic peptides inhibit protein synthesis by targeting the eukaryotic elongation factor-1α. A potentially related cytotoxic natural product ('A3') was isolated from Aspergillus, but only 4 of its 11 stereocentres could be assigned. Here, we synthesized SR-A3 and SS-A3-two out of 128 possible A3 epimers-and discovered that synthetic SR-A3 is indistinguishable from naturally derived A3. Relative to SS-A3, SR-A3 exhibits an enhanced residence time and rebinding kinetics, as revealed by single-molecule fluorescence imaging of elongation reactions catalysed by eukaryotic elongation factor-1α in vitro. An increased residence time-stereospecifically conferred by the unique β-hydroxyl in SR-A3-was also observed in cells. Consistent with its prolonged duration of action, thrice-week</pubmed_abstract><journal>Nature chemistry</journal><pubmed_title>Synthesis and single-molecule imaging reveal stereospecific enhancement of binding kinetics by the antitumour eEF1A antagonist SR-A3.</pubmed_title><pmcid>PMC10018702</pmcid><funding_grant_id>R35 CA242986</funding_grant_id><funding_grant_id>T32 GM145460</funding_grant_id><funding_grant_id>R01 GM079238</funding_grant_id><funding_grant_id>R01 GM098859</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Weber JF</pubmed_authors><pubmed_authors>Al-Khdhairawi AAQ</pubmed_authors><pubmed_authors>Blanchard SC</pubmed_authors><pubmed_authors>Oltion K</pubmed_authors><pubmed_authors>Tom H</pubmed_authors><pubmed_authors>Taunton J</pubmed_authors><pubmed_authors>Ruggero D</pubmed_authors><pubmed_authors>Holm M</pubmed_authors><pubmed_authors>Wang HY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and single-molecule imaging reveal stereospecific enhancement of binding kinetics by the antitumour eEF1A antagonist SR-A3.</name><description>Ternatin-family cyclic peptides inhibit protein synthesis by targeting the eukaryotic elongation factor-1α. A potentially related cytotoxic natural product ('A3') was isolated from Aspergillus, but only 4 of its 11 stereocentres could be assigned. Here, we synthesized SR-A3 and SS-A3-two out of 128 possible A3 epimers-and discovered that synthetic SR-A3 is indistinguishable from naturally derived A3. Relative to SS-A3, SR-A3 exhibits an enhanced residence time and rebinding kinetics, as revealed by single-molecule fluorescence imaging of elongation reactions catalysed by eukaryotic elongation factor-1α in vitro. An increased residence time-stereospecifically conferred by the unique β-hydroxyl in SR-A3-was also observed in cells. Consistent with its prolonged duration of action, thrice-week</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-05-29T22:11:49.114Z</modification><creation>2025-05-29T22:11:49.114Z</creation></dates><accession>S-EPMC10018702</accession><cross_references><pubmed>36123449</pubmed><doi>10.1038/s41557-022-01039-3</doi></cross_references></HashMap>